Journal article
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease
X Huang, Y Li, C Fowler, JD Doecke, YY Lim, C Drysdale, V Zhang, K Park, B Trounson, K Pertile, R Rumble, JW Pickering, RA Rissman, F Sarsoza, S Abdel-Latif, Y Lin, V Doré, V Villemagne, CC Rowe, J Fripp Show all
Alzheimer S and Dementia | WILEY | Published : 2023
DOI: 10.1002/alz.12813
Abstract
Introduction: Blood-based diagnostics and prognostics in sporadic Alzheimer's disease (AD) are important for identifying at-risk individuals for therapeutic interventions. Methods: In three stages, a total of 34 leukocyte antigens were examined by flow cytometry immunophenotyping. Data were analyzed by logistic regression and receiver operating characteristic (ROC) analyses. Results: We identified leukocyte markers differentially expressed in the patients with AD. Pathway analysis revealed a complex network involving upregulation of complement inhibition and downregulation of cargo receptor activity and Aβ clearance. A proposed panel including four leukocyte markers – CD11c, CD59, CD91, and ..
View full abstractRelated Projects (3)
Grants
Awarded by National Institutes of Health
Funding Acknowledgements
ARC Future Fellowship, Grant/Award Number: FT120100581; NHMRC, Grant/Award Numbers: 1048082, 1061419, 1120095, 110178; Ministry of Science and Technology of China, Grant/Award Number: SQ2018YFC200022; Bethlehem Griffiths Research Foundation, Grant/Award Number: BGRF1901; Victorian Government's Operational Infrastructure; Florey Institute; NIA; NIH, Grant/Award Numbers: AG058252, AG073979, AG051848